Rationale: The most effective approach to teach respiratory inhaler technique is unknown.
Asthma and chronic obstructive pulmonary disease (COPD) are the most common lung diseases in the United States, with over one-million hospitalizations annually. 1 Medications delivered through respiratory inhaler devices are guideline-recommended for rescue and controller therapy to decrease symptoms, exacerbations, need for rescue medications, and to improve quality of life and lung function. 2--6 However, inhaler devices require multiple, sometimes complex, steps making them difficult to use. [7] [8] [9] [10] [11] Patients often do not know, or cannot effectively complete, these steps, resulting in misuse. 12, 13 Studies suggest that 28-68% of outpatients 14, 15 and 62-86% of inpatients 13 misuse inhaler devices, placing patients at increased risk for poor health outcomes and future hospitalizations. 17, 18 The cost of inhaler misuse accounts for $5-7 billion of the approximately $25 billion spent annually on inhalers. 16 Current guidelines address this risk for misuse by recommending inhaler technique assessment and instruction during all health care encounters, including hospitalizations.
2,3
Hospital-based self-management education may be useful since experience with acute illness can be harnessed as a 'teachable moment.' 19 Teach-to-Goal (TTG) instruction, 12, 13 based on the testing effect, allowing memory to be enhanced through the act of retrieving information while learning, 20 is comprised of tailored rounds of assessment and instruction to achieve the goal knowledge or skill. 7, 12, 13, 21 We demonstrated in a prior study that hospital-based TTG has greater efficacy than verbal instructions (brief intervention) immediately post-instruction in the hospital. 13 However, the longer-term duration of effects of hospital-based TTG on inhaler technique and acute care events after discharge home are unknown. This knowledge may help inform what methods of education are most effective in improving outcomes after discharge among patients using inhalers.
The objectives of this two-center randomized clinical trial among inpatients with asthma or COPD were to compare the effects of hospital-based TTG compared to brief intervention on inhaler technique and acute care events at 30 and 90 days after discharge home. We hypothesized that among participants with asthma or COPD receiving inpatient education, MDI misuse would be significantly lower among TTG participants than brief intervention participants at 30-days post-hospital discharge. Some of the results of these studies have been previously reported in abstract form.
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Methods
Study Design and Randomization
We conducted a two-site block-stratified randomized clinical trial comparing TTG and brief intervention educational interventions. Participants were assigned to interventions stratified by site (hospital #1 and #2) and health literacy level (adequate, low, or insufficient vision to complete the health literacy assessment). 25 Study personnel were masked to intervention assignments. Participants received compensation for their time. The Institutional Review
Boards at University of Chicago Medicine and Mercy Hospital and Medical Center, Chicago, approved the study.
Study Participants and Procedures
Patients were eligible if they were 18-years or older, hospitalized with a physician diagnosis of asthma or COPD, and were being discharged using a pressurized metered-dose inhaler (MDI) 
Intervention
Participants were randomized to TTG or brief intervention and were provided instructions on 12-step MDI-with-spacer (all patients) and 10-step Diskus® (only those prescribed) instructions, as per our previously published approach [ Figure 4 ]. Detailed descriptions and rationale are available as an online supplement. 13 The interventions were delivered by trained research educators who were masked to the other strategy to prevent contamination, and were consistent across sites. Participants returned for in-person study visits at 30 (+/-7) and 90 (+/-14) days.
Outcomes
The primary outcome was MDI misuse at 30 days post-discharge. The study was powered at 80% for an effect size of ≥20% improvement of TTG compared to the brief intervention group. To ascertain whether baseline misuse and/or other patient characteristics factored into group differences at the 30 and 90 day time points, secondary analyses examined MDI misuse as a repeated measures variable, adjusting for baseline MDI misuse, Diskus® use, health literacy, sex, and race using generalized estimating equations (GEE) model.
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A post-hoc sensitivity analysis evaluating MDI technique was performed using two additional 'misuse' cutoffs: 1) using chi-square to dichotomize misuse if participants only missed 'mission critical' steps as advised by pulmonary specialists, that would, if missed, result in no medication reaching the lungs (removing cap; activating inhaler); and 2) using linear regression of misuse based on the delta score at 30 days versus immediately post-education.
Fisher exact tests were used to test for differences in acute care events between groups.
All analyses were performed using intention-to-treat analyses. Tests of significance used a two-sided p-value <0.05. STATA version 12 (College Station, Texas: StataCorp LP) was used.
Results
A total of 872 patients were screened to participate in the study, of whom 120 were eligible.
Participants were randomized into TTG (n=62) or brief intervention groups (n=58) between September 2011 and February 2013 ( Figure 1 ). Of the 120 participants, 100 were enrolled at hospital #1 and 20 were enrolled from hospital #2. Among enrolled participants, the median age was 48.5 years (IQR: 35-58); the majority were female and African American.
Most participants returned for their 30 day (n=107, 89%; TTG n=54, 87%; brief intervention n=53, 91%), and 90 day (n=103, 86%; TTG n=52, 84%; brief intervention n=51, 88%)
follow-up visits. Only 32% of participants were prescribed a Diskus® for use post-discharge.
Eighty-three percent of participants reported having a healthcare provider for their asthma or COPD. Two-thirds were hospitalized at least once in the last year and nearly one-half had had a near-fatal event in their lifetime (Table 1) . Baseline characteristics and inhaler technique (MDI and Diskus®) were similar in both the TTG and the brief interventiongroups (Figure 2a ). The average time for TTG education was 6 minutes versus 2 minutes for the brief intervention group.
All 120 participants completed the pre-and post-education evaluations in the hospital.
At 30 days after hospital discharge, there were no significant differences in participant characteristics between those who completed the assessments compared to those who were lost to follow-up (Table 2 ). However, participants with a prior near-fatal event (53% vs 24%, p=0.03) were more likely to return to the 90 day follow-up visit.
MDI technique improved immediately post-education with decreased proportions of misuse for both the TTG (92% to 11%, p<0.001) and the brief intervention groups (84% to 60%, p<0.001). However, the reduction in misuse was greater with the TTG group versus the brief intervention group (TTG 81% vs brief intervention 24%, p<0.001). (Figure 2a )
Post-Discharge MDI Technique
The proportion of participants who misused MDIs during the first 30 days after hospital discharge in the TTG group (54%) versus the brief intervention group (70%) was not significantly different (p=0.1). Among participants who received TTG education, the proportion of MDI misuse immediately post-hospital education versus 30 days after hospital discharge increased from 11% to 54% (p<0.001; Figure 2a ). The proportion of misuse within the brief intervention group did not change significantly at 30 days versus immediate post-hospital education (70% vs 60%, p=0.1). At 90 days, the proportion of participants with MDI misuse was significantly lower in the TTG group versus the brief intervention group (48% vs 76%, p=0.004).
In multivariable analyses that accounted for baseline MDI misuse, use of Diskus® device, health literacy, sex, and race, the odds of MDI misuse in the brief intervention group at 30 days group. These data suggested that participants educated via TTG retained knowledge of critical steps in the use of MDI better than those educated using brief intervention.
When examining potential differences between subgroups, no significant differences between sites were found for MDI technique at each time point analyzed. There were also no differences in MDI misuse between the TTG group and brief intervention group by health literacy group at 30 days; those with adequate health literacy had a lower odds of MDI misuse at 90 days in the TTG group compared to the brief intervention group (p=0.03) ( Figure 2b ).
We did not observe effect modification by health literacy on the association between MDI misuse and TTG versus the brief intervention group at post-education, 30 day, or 90 day follow-up. Additionally, using multivariate analysis, after adjusting for sex, race, and health literacy level, the odds of MDI misuse remained significantly lower in the TTG group compared to the brief intervention group at post-education (p<0.001) and at 90 day follow-up (p=0.005),
but not at 30 day follow-up (p=0.06). This analysis suggested that TTG was broadly applicable and superior to brief intervention for MDI in the different subgroups and literacy levels in our patient population.
Post-Discharge Diskus® Technique
Among patients who were prescribed a Diskus® device, TTG-based education was superior to the brief intervention with a significantly lower proportion of misuse immediately following education (5% vs 61%, p=0.001). In the TTG group, Diskus® misuse increased from 5%
immediately post-education to 53% at 30 days post-discharge (p=0.001); there was no significant change in Diskus® misuse in the brief intervention group during the same time period (61% vs 59%, p=0.9). We did not observe a significant change in Diskus® misuse at 90 days compared to 30 days post-discharge in either TTG (90 days: 38% vs 30 days: 53%, p=0.3) or brief intervention groups (90 days: 62% vs 30 days: 59%, p=0.5). In addition, at 90 days, Diskus® misuse was common and not significantly different between the TTG and brief intervention groups (38% vs 63%, p=0.2).
Multi-inhaler (MDI + Diskus®) Technique
For patients using both MDI and Diskus® (n=38), 39% misused at least one device (15/38) and 18.4% (7/38) misused both devices post-education (p=0.005). We observed higher risk of misuse for those using multiple devices at baseline (p=0.02), but not after teaching began (p>0.05). Among the 34 participants using both devices at 30 days post-discharge, we observed a significant association between MDI and Diskus® misuse (p=0.04). For instance, of the participants who misused at least one device (24/34, 71%), over half misused both devices (14/24, 58%).
Among the 32 participants using both devices at 90 days post-discharge, the association between MDI and Diskus® misuse remained (p=0.01). Of the 21 participants misusing at least one device (66%), 13 individuals misused both devices (62%).
Our analysis of confounding by multiple device use found no significant differences in misuse between TTG and brief intervention groups at any time point (post-education, p=0.06; 30 day post-discharge, p=0.19; 90 day post-discharge, p=0.06).
Acute Care Events Post-Discharge
Overall, 23% (28/120) of participants reported an acute care event at 30 days after hospital discharge ( Figure 3 ). Fewer events (17%, 9/54) occurred in the TTG compared to the brief intervention group (36%, 19/53, p=0.03). At 90 days post-discharge, 36% (43/120) of participants reported an acute care event for any cause (36%, 43/120 reported an ED visit; 22%, 26/120 reported a hospitalization). There were no longer any differences in the proportion with acute care events in the TTG group compared to the brief intervention group (34% vs 38%, p=0.6).
Participants with low health literacy (n=23) were more likely than participants with adequate health literacy (n=79) to have had an acute care event within 30 days after discharge 
Discussion
To our knowledge, this study is the first in hospitalized patients with asthma or COPD to directly compare hospital-based education strategies on the durability and lasting effects of hospitalbased education after discharge home for inhaler technique and acute care events. Two principal findings emerged. First, TTG is superior to a brief education intervention for reducing initial inhaler misuse. However, the overall benefit of TTG wanes such that the difference in MDI misuse between the two groups is not significant by 30 days. Second, the group that received TTG education was significantly less likely to have acute care events at 30 days (but not 90 days) after hospital discharge. Further, TTG appeared to be particularly protective for patients with low health literacy.
Importantly, together these findings suggest that TTG may be a superior initial strategy for inhaler instruction, and that there may be improved clinical outcomes to providing TTG inpatient inhaler education, especially for patients with lower health literacy levels, but that reinforcement of inhaler technique is required after discharge for long-lasting skills retention and improved health outcomes.
TTG's superior effect compared to a brief education intervention on reducing inhaler misuse among inpatients, initially reported in earlier work, 13 was re-demonstrated in this study.
However, this study newly found that these observed differences in MDI misuse between TTG and brief intervention at later time-points were smaller, and although the differences favored the TTG group at both 30 and 90 days, the differences were not consistently significantly different. Despite the decaying skills, however, TTG participants returned less often for acute care events within a month; this was true even for participants with low health literacy and did not differ with respect to medication adherence post-discharge. Of note, within three months differences in acute care utilization did not differ by group, despite differences in misuse; future work should explore the relationship to longer term skill retention and impact on clinical outcomes.
The implications of these two findings are that TTG not only provides initial improvement in inhaler technique, but also that these enhanced skills may persist long enough to provide initial post-discharge benefit. However, due to the declining skills and the lack of persistent differences in clinical outcomes by 3 months, additional educational sessions or "doses" may be needed for ongoing effective technique and longer term beneficial health outcomes.
Participants' decay of inhaler technique was not surprising, as skill decay is expected with complex tasks, based on the cognitive psychology literature. 28 Decay of skills are based on many factors, including the nature of the task and time between use. 29 Teach-to-goal may have an advantage over brief intervention, through its repeated cycles, as TTG provides for an opportunity of 'overlearning' 29 and uses the cognitive psychology phenomenon of the 'testing effect' that can mitigate skill decay. 20, 29 This may be observed when looking within groups between the 30-days post discharge proportion with MDI misuse compared to baseline misuse: MDI misuse at 30 days post discharge among TTG participants was half what it was before TTG education, while brief intervention misuse was only down by about a tenth from baseline. However, even TTG's use of 'overlearning' and the testing effect phenomenon would not be expected to be sufficient to completely overcome decay. Therefore, repeated dosing of skill education is supported both by clinical guidelines that suggest assessing and teaching self-management skills at all health encounters, and by psychology literature that says that regular repetition is required to avoid decay. 29 Since the misuse largely plateaued by 30 days, most of the skill decay had already likely occurred. Therefore, the ideal time for the repeated education would be before one month post-discharge.
Strengths and Limitations
Our study had multiple strengths, including random allocation to two different educational strategies, masking of research personnel to avoid contamination of educational interventions between study groups or biased collection of outcomes, and high post-discharge follow-up rates.
The study also has potential limitations. Findings from our largely high-risk, nearly half of whom had a prior near-fatal respiratory exacerbation, African American study population, may not be applicable to other patient populations. The interventions in our study were delivered by trained research staff; whether such interventions are effective when delivered by trained clinical staff needs study. We assessed acute care events after hospital discharge and inhaler use and adherence based on self-report. Problems with recall and lack of objective verification may result in less accurate data. However, follow-up rates at 30 days were similarly high in both groups (nearly 90%) and it is unlikely that patients in the two groups would have differential recall. Future work can employ objective adherence monitoring for MDIs.
Our sample size for participants using Diskus® was only ome-third of the enrolled population, therefore, the findings regarding Diskus®, including multiple inhaler use results, require further study. Participants with both asthma and COPD were included in this study and important differences by sub-population may exist, whether due to disease type, age or other potential mediators. Future work can delineate if and how the effects of TTG versus brief intervention differ among the two groups. Further, our patient population had a high rate of life-time near fatal events, indicating a patient population that may learn differently than a healthier population. Effects of TTG on outpatients' ability to learn and retain inhaler technique skills is warranted.
Finally, while TTG is a relatively inexpensive strategy compared with expenses associated with exacerbations, the need for in-person educators may be cost and/or time prohibitive in some settings. Therefore, future work can explore the development of alternate strategies that allow for harnessing the strengths of TTG without resource burden of personnel.
Conclusions
These findings emphasize the need for self-management training for inhaler technique at all health care encounters. Results of our study provide justification for developing and implementing hospital-based strategies, such as TTG, to educate patients about use of their respiratory inhalers, but also suggest the need for post-discharge education, such as when patients present for care in the ambulatory setting, or even at home. Strategies including novel technology-based educational platforms that can be provided initially in the hospital and then extended post-discharge may add value to chronic disease self-management education.
Our data emphasize the critical need for post-discharge educational reinforcement of hospitalbased education. The ideal timing, method, and location of this additional education, in addition to more robust evaluation of inhaler technique skill on adherence and health outcomes is important future work. Identified either a general physician, specialist physician (pulmonologist or allergist), or nurse practionner as providing care for participants' asthma or COPD. 
All data presented as n (%) unless otherwise indicated. Baseline (BL) completers (C): n=120; 30 day completers (C): n=107; loss to follow-up: (L) n=13; 90 day completers (C): n=103; loss to follow-up (L): n=17.
*Ever smoker defined as >100 lifetime cigarettes vs never smoker † Insufficient vision defined as worse than 20/50 vision in both eyes using Snellen ‡ Health literacy was assessed in 102 participants; brief intervention (n=50); TTG (n=52); remaining subjects had insufficient vision to complete assessment (x=18); less-than adequate health literacy was defined as score of <23/36 on Short Test of Functional Health Literacy (STOHFLA) § Did not identify a general physician, specialist physician (pulmonologist or allergist), or nurse practionner as providing care for participants' asthma or COPD. 
Study Participants: Identification of Eligible Patients, Eligibility and Exclusion Criteria
RAs screened for admissions using each hospitals' respective electronic health record (EPIC and Cerner) Monday through Friday. Patients who were 18-years or older, hospitalized on an inpatient medical service, had a physician diagnosis of asthma or COPD as documented in the medical record and/or confirmed by inpatient primary team, and expected to be discharged home on an MDI by their inpatient physician, were eligible for inclusion. Patients who were currently in an intensive care setting, lacked physician assent, or were unable to provide written informed consent were excluded from the study.
Study Procedures
Interviewers administered surveys to collect participant demographic data. Participants' baseline acute-care utilization for asthma or COPD was measured using the number of hospitalizations for asthma or COPD in the past 12-months and any lifetime near-fatal respiratory event (≥1 intensive care unit admission(s) and/or intubation). [1] [2] [3] Prior to administering the S-TOFHLA, vision was assessed (Snellen screening chart); 1,3 participants who used corrective-lenses were instructed to wear them. Vision worse than 20/50 in both eyes was defined as insufficient to complete the STOFHLA instrument.
Inhaler technique was assessed by a trained RA using detailed step-wise checklists for MDI (12-steps) and when applicable, Diskus (10-steps), described and published in our prior work. 4, 5 The primary analysis used the definition of MDI misuse as performing <75% of steps correctly for the MDI (<9/12 steps). [4] [5] [6] [7] However, due to the non-standardization of this variable, a sensitivity analysis evaluating inhaler technique was performed using two additional methods: 
Follow-up Visits
To evaluate durability of the hospital-based inhaler instruction, participants returned at 30-days (+/-7days) and 3-months (+/-2 weeks). At each visit, the RA re-evaluated participants'
technique. In addition, the RA administered questionnaires regarding symptoms, utilization of acute-care services (defined as: ≥ 1 all-cause emergency department (ED) visits, hospitalizations), and use of inhalers including both rescue MDIs and controller Diskus devices (when prescribed).
Outcomes
The primary outcome, determined a priori, was MDI misuse at 30-days post-education. This study was designed to detect a 20% absolute difference in MDI misuse between TTG and BI arms achieving a power of 85%. Secondary outcomes included MDI misuse at other time-points (immediately after education in the hospital and 3-months post-discharge); all-cause acute-care events at 30-days and 3-months; and self-reported confidence for MDI use); and subgroup analyses by site and health literacy.
Statistical Analyses
Participant characteristics were described using proportions and measures of central tendency (mean, standard deviations [SD]; median, IQR). Two sample t-tests and Mann-Whitney U tests were used to compare baseline characteristics between groups as appropriate. Chi-squared and
Fisher exact tests were used to test for differences in the prevalence of MDI misuse and acute within BI and TTG, individually.
All analyses were performed with intention-to-treat analyses; tests of significance used a two-sided p-value of less than 0.05. All statistical analyses were performed using STATA version 12 (College Station, Texas: StataCorp LP).
